Gossamer Bio Inc (NASDAQ:GOSS)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - GOSS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - GOSS

  • Market Cap$781.300m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS38341P1021

Company Profile

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include GB001 (DP2 Antagonist), GB002 (PDGF Receptor Kinase Inhibitor), GB004 (HIF-1a Stabilizer), and GB1275 (CD11b Modulator).

Latest GOSS news

Currently there for this company. Visit our news hub for other news .